Loading...
Please wait, while we are loading the content...
Similar Documents
Studio multicentrico in aperto sull’efficacia differenziale a medio termine, del trattamento con Aloperidolo, Clozapina, Olanzapina e Risperidone in pazienti schizofrenici
| Content Provider | Semantic Scholar |
|---|---|
| Author | Caredda, Maria Pacitti, F. Pancheri, Paolo |
| Copyright Year | 2006 |
| Abstract | Introduction There has been considerable support for the observation that atypical antipsychotics have a broader range of therapeutic effects than traditional antipsychotics. Specifically, they appear to be superior in terms of improvement of negative, cognitive, and affective symptoms in patients with schizophrenia. The purpose of this study was to compare the long-term efficacy of SGAs (Clozapine, Olanzapine, Risperidone) and FGAs (Haloperidol) on the different symptoms of schizophrenia. The analysis had 2 principal objectives: 1. to assess whether a significant change over time occurred in any of the 4 treatment groups; 2. to test whether there is a slope difference between the 4 medication groups in syndrome change trajectories over time. |
| File Format | PDF HTM / HTML |
| Volume Number | 12 |
| Alternate Webpage(s) | http://www.jpsychopathol.it/issues/2006/vol12-2/caredda.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
